Theradex Oncology (United States)

Reversal of tumor-induced immunosuppression: a new approach to cancer therapy.

Slawomir Wojtowicz‐Praga · PubMed · 1997 · 224 citations

Life Sciences, Immunology, Oncology +17

Reversal of Tumor-Induced Immunosuppression: A New Approach to Cancer Therapy

Slawomir Wojtowicz‐Praga · Journal of Immunotherapy · 1997 · 189 citations

Life Sciences, Immunology, Oncology +17

Dose–response study of recombinant human soluble thrombomodulin (ART‐123) in the prevention of venous thromboembolism after total hip replacement

Clive Kearon, Philip C. Comp, James D. Douketis et al. · Journal of Thrombosis and Haemostasis · 2005 · 73 citations · Full text

Medicine, Orthopedic Surgery, Pharmacology +17

Final results of a phase II multicenter trial of HF10, a replication-competent HSV-1 oncolytic virus, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma.

Robert Hans Ingemar Andtbacka, Merrick I. Ross, Sanjiv S. Agarwala et al. · Journal of Clinical Oncology · 2017 · 55 citations

Pharmacy, Oncology, Pharmacotherapy +17

Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours

Hussein Tawbi, Liza C. Villaruz, Ahmad A. Tarhini et al. · British Journal of Cancer · 2011 · 36 citations · Full text

Medicine, Oncology, Pharmacology +15